Researchers reported, “Symptom relief was greatest after consumption of plant variants with slightly higher than average levels of the terpenes myrcene and terpinolene.”
Topic: Marijuana Research
Browse these news releases for articles that indicate laws or changes on how marijuana research is conducted. For articles about specific topics of “Research Studies” please choose that topic.
Investigators reported reductions in patients’ agitation, apathy, irritability, sleep disturbances, and eating disturbances following cannabis treatment.
Lifetime heavy cannabis use was associated with decreased blood pressure, authors concluded.
“This is the first published study examining long-term cannabis efficacy in chronic combat treatment-resistant PTSD patients,” authors acknowledged.
Among those taking prescription medications at the onset of the study, 65% ceased their use of opioids, 60% stopped using antidepressants, and 58% ceased their use of anticonvulsants.
Cannabis therapy was associated with sustained improvements in pain, anxiety, sleep, and other health-related outcomes.
“Our research found CBC to enhance the cytotoxic effect of CBD, establishing additional support for the phenomenon of the entourage effect,” investigators concluded.
Under the new law, the Attorney General is provided with a 60-day timeline to either approve or deny applications from scientists wishing to conduct human trials with cannabis.